Epidemiology of parvovirus B19 and anemia among kidney transplant recipients: A meta-analysis

Background: Persistent anemia has been described in kidney transplant (KTx) recipients with parvovirus B19 virus infection. However, the epidemiology of parvovirus B19 and parvovirus B19-related anemia after KTx remains unclear. We conducted this systematic review (1) to investigate the incidence of...

Full description

Saved in:
Bibliographic Details
Published in:Urology annals Vol. 12; no. 3; pp. 241 - 247
Main Authors: Thongprayoon, Charat, Khoury, Nadeen, Bathini, Tarun, Aeddula, Narothama, Boonpheng, Boonphiphop, Lertjitbanjong, Ploypin, Watthanasuntorn, Kanramon, Leeaphorn, Napat, Chesdachai, Supavit, Torres-Ortiz, Aldo, Kaewput, Wisit, Bruminhent, Jackrapong, Mao, Michael, Cheungpasitporn, Wisit
Format: Journal Article
Language:English
Published: India Wolters Kluwer India Pvt. Ltd 01-07-2020
Medknow Publications and Media Pvt. Ltd
Medknow Publications & Media Pvt. Ltd
Wolters Kluwer - Medknow
Wolters Kluwer Medknow Publications
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Background: Persistent anemia has been described in kidney transplant (KTx) recipients with parvovirus B19 virus infection. However, the epidemiology of parvovirus B19 and parvovirus B19-related anemia after KTx remains unclear. We conducted this systematic review (1) to investigate the incidence of parvovirus B19 infection after KTx and (2) to assess the incidence of parvovirus B19 among KTx patients with anemia. Materials and Methods: A systematic review was conducted in EMBASE, MEDLINE, and Cochrane databases from inception to March 2019 to identify studies that reported the incidence rate of parvovirus B19 infection and/or seroprevalence of parvovirus B19 in KTx recipients. Effect estimates from the individual studies were extracted and combined using random-effects, generic inverse variance method of DerSimonian and Laird. The protocol for this systematic review is registered with PROSPERO (no. CRD42019125716). Results: Nineteen observational studies with a total of 2108 KTx patients were enrolled. Overall, the pooled estimated seroprevalence of parvovirus B19 immunoglobulin G was 62.2% (95% confidence interval [CI]: 45.8%-76.1%). The pooled estimated incidence rate of positive parvovirus B19 DNA in the 1st year after KTx was 10.3% (95% CI: 5.5%-18.4%). After sensitivity analysis excluded a study that solely included KTx patients with anemia, the pooled estimated incidence rate of positive parvovirus B19 DNA after KTx was 7.6% (95% CI: 3.7%-15.0%). Among KTx with anemia, the pooled estimated incidence rate of positive parvovirus B19 DNA was 27.4% (95% CI: 16.6%-41.7%). Meta-regression analysis demonstrated no significant correlations between the year of study and the incidence rate of positive parvovirus B19 DNA (P = 0.33). Egger's regression asymmetry test was performed and demonstrated no publication bias in all analyses. Conclusion: The overall estimated incidence of positive parvovirus B19 DNA after KTX is 10.3%. Among KTx with anemia, the incidence rate of positive parvovirus B19 DNA is 27.4%. The incidence of positive parvovirus B19 DNA does not seem to decrease overtime.
AbstractList BACKGROUNDPersistent anemia has been described in kidney transplant (KTx) recipients with parvovirus B19 virus infection. However, the epidemiology of parvovirus B19 and parvovirus B19-related anemia after KTx remains unclear. We conducted this systematic review (1) to investigate the incidence of parvovirus B19 infection after KTx and (2) to assess the incidence of parvovirus B19 among KTx patients with anemia. MATERIALS AND METHODSA systematic review was conducted in EMBASE, MEDLINE, and Cochrane databases from inception to March 2019 to identify studies that reported the incidence rate of parvovirus B19 infection and/or seroprevalence of parvovirus B19 in KTx recipients. Effect estimates from the individual studies were extracted and combined using random-effects, generic inverse variance method of DerSimonian and Laird. The protocol for this systematic review is registered with PROSPERO (no. CRD42019125716). RESULTSNineteen observational studies with a total of 2108 KTx patients were enrolled. Overall, the pooled estimated seroprevalence of parvovirus B19 immunoglobulin G was 62.2% (95% confidence interval [CI]: 45.8%-76.1%). The pooled estimated incidence rate of positive parvovirus B19 DNA in the 1st year after KTx was 10.3% (95% CI: 5.5%-18.4%). After sensitivity analysis excluded a study that solely included KTx patients with anemia, the pooled estimated incidence rate of positive parvovirus B19 DNA after KTx was 7.6% (95% CI: 3.7%-15.0%). Among KTx with anemia, the pooled estimated incidence rate of positive parvovirus B19 DNA was 27.4% (95% CI: 16.6%-41.7%). Meta-regression analysis demonstrated no significant correlations between the year of study and the incidence rate of positive parvovirus B19 DNA (P = 0.33). Egger's regression asymmetry test was performed and demonstrated no publication bias in all analyses. CONCLUSIONThe overall estimated incidence of positive parvovirus B19 DNA after KTX is 10.3%. Among KTx with anemia, the incidence rate of positive parvovirus B19 DNA is 27.4%. The incidence of positive parvovirus B19 DNA does not seem to decrease overtime.
Background: Persistent anemia has been described in kidney transplant (KTx) recipients with parvovirus B19 virus infection. However, the epidemiology of parvovirus B19 and parvovirus B19-related anemia after KTx remains unclear. We conducted this systematic review (1) to investigate the incidence of parvovirus B19 infection after KTx and (2) to assess the incidence of parvovirus B19 among KTx patients with anemia. Materials and Methods: A systematic review was conducted in EMBASE, MEDLINE, and Cochrane databases from inception to March 2019 to identify studies that reported the incidence rate of parvovirus B19 infection and/or seroprevalence of parvovirus B19 in KTx recipients. Effect estimates from the individual studies were extracted and combined using random-effects, generic inverse variance method of DerSimonian and Laird. The protocol for this systematic review is registered with PROSPERO (no. CRD42019125716). Results: Nineteen observational studies with a total of 2108 KTx patients were enrolled. Overall, the pooled estimated seroprevalence of parvovirus B19 immunoglobulin G was 62.2% (95% confidence interval [CI]: 45.8%–76.1%). The pooled estimated incidence rate of positive parvovirus B19 DNA in the 1st year after KTx was 10.3% (95% CI: 5.5%–18.4%). After sensitivity analysis excluded a study that solely included KTx patients with anemia, the pooled estimated incidence rate of positive parvovirus B19 DNA after KTx was 7.6% (95% CI: 3.7%–15.0%). Among KTx with anemia, the pooled estimated incidence rate of positive parvovirus B19 DNA was 27.4% (95% CI: 16.6%–41.7%). Meta-regression analysis demonstrated no significant correlations between the year of study and the incidence rate of positive parvovirus B19 DNA (P = 0.33). Egger's regression asymmetry test was performed and demonstrated no publication bias in all analyses. Conclusion: The overall estimated incidence of positive parvovirus B19 DNA after KTX is 10.3%. Among KTx with anemia, the incidence rate of positive parvovirus B19 DNA is 27.4%. The incidence of positive parvovirus B19 DNA does not seem to decrease overtime.
Background: Persistent anemia has been described in kidney transplant (KTx) recipients with parvovirus B19 virus infection. However, the epidemiology of parvovirus B19 and parvovirus B19-related anemia after KTx remains unclear. We conducted this systematic review (1) to investigate the incidence of parvovirus B19 infection after KTx and (2) to assess the incidence of parvovirus B19 among KTx patients with anemia. Materials and Methods: A systematic review was conducted in EMBASE, MEDLINE, and Cochrane databases from inception to March 2019 to identify studies that reported the incidence rate of parvovirus B19 infection and/or seroprevalence of parvovirus B19 in KTx recipients. Effect estimates from the individual studies were extracted and combined using random-effects, generic inverse variance method of DerSimonian and Laird. The protocol for this systematic review is registered with PROSPERO (no. CRD42019125716). Results: Nineteen observational studies with a total of 2108 KTx patients were enrolled. Overall, the pooled estimated seroprevalence of parvovirus B19 immunoglobulin G was 62.2% (95% confidence interval [CI]: 45.8%-76.1%). The pooled estimated incidence rate of positive parvovirus B19 DNA in the 1st year after KTx was 10.3% (95% CI: 5.5%-18.4%). After sensitivity analysis excluded a study that solely included KTx patients with anemia, the pooled estimated incidence rate of positive parvovirus B19 DNA after KTx was 7.6% (95% CI: 3.7%-15.0%). Among KTx with anemia, the pooled estimated incidence rate of positive parvovirus B19 DNA was 27.4% (95% CI: 16.6%-41.7%). Meta-regression analysis demonstrated no significant correlations between the year of study and the incidence rate of positive parvovirus B19 DNA (P = 0.33). Egger's regression asymmetry test was performed and demonstrated no publication bias in all analyses. Conclusion: The overall estimated incidence of positive parvovirus B19 DNA after KTX is 10.3%. Among KTx with anemia, the incidence rate of positive parvovirus B19 DNA is 27.4%. The incidence of positive parvovirus B19 DNA does not seem to decrease overtime.
Persistent anemia has been described in kidney transplant (KTx) recipients with parvovirus B19 virus infection. However, the epidemiology of parvovirus B19 and parvovirus B19-related anemia after KTx remains unclear. We conducted this systematic review (1) to investigate the incidence of parvovirus B19 infection after KTx and (2) to assess the incidence of parvovirus B19 among KTx patients with anemia. A systematic review was conducted in EMBASE, MEDLINE, and Cochrane databases from inception to March 2019 to identify studies that reported the incidence rate of parvovirus B19 infection and/or seroprevalence of parvovirus B19 in KTx recipients. Effect estimates from the individual studies were extracted and combined using random-effects, generic inverse variance method of DerSimonian and Laird. The protocol for this systematic review is registered with PROSPERO (no. CRD42019125716). Nineteen observational studies with a total of 2108 KTx patients were enrolled. Overall, the pooled estimated seroprevalence of parvovirus B19 immunoglobulin G was 62.2% (95% confidence interval [CI]: 45.8%-76.1%). The pooled estimated incidence rate of positive parvovirus B19 DNA in the 1 year after KTx was 10.3% (95% CI: 5.5%-18.4%). After sensitivity analysis excluded a study that solely included KTx patients with anemia, the pooled estimated incidence rate of positive parvovirus B19 DNA after KTx was 7.6% (95% CI: 3.7%-15.0%). Among KTx with anemia, the pooled estimated incidence rate of positive parvovirus B19 DNA was 27.4% (95% CI: 16.6%-41.7%). Meta-regression analysis demonstrated no significant correlations between the year of study and the incidence rate of positive parvovirus B19 DNA ( = 0.33). Egger's regression asymmetry test was performed and demonstrated no publication bias in all analyses. The overall estimated incidence of positive parvovirus B19 DNA after KTX is 10.3%. Among KTx with anemia, the incidence rate of positive parvovirus B19 DNA is 27.4%. The incidence of positive parvovirus B19 DNA does not seem to decrease overtime.
Audience Academic
Author Leeaphorn, Napat
Bathini, Tarun
Cheungpasitporn, Wisit
Boonpheng, Boonphiphop
Watthanasuntorn, Kanramon
Aeddula, Narothama
Lertjitbanjong, Ploypin
Chesdachai, Supavit
Kaewput, Wisit
Torres-Ortiz, Aldo
Khoury, Nadeen
Bruminhent, Jackrapong
Thongprayoon, Charat
Mao, Michael
AuthorAffiliation 7 Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA
6 Department of Medicine, Renal Transplant Program, University of Missouri-Kansas City School of Medicine, Saint Luke's Health System, Kansas City, Missouri, USA
1 Department of Medicine, Division of Nephrology, Henry Ford Hospital, Detroit, Michigan, USA
8 Department of Medicine, Division of Nephrology, University of Mississippi Medical Center, Jackson, Mississippi, USA
Department of Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Rochester, USA
2 Department of Internal Medicine, University of Arizona, Tucson, Arizona, USA
10 Department of Medicine, Division of Infectious Diseases, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
5 Department of Internal Medicine, Bassett Medical Center, Cooperstown, New York, USA
3 Department of Medicine, Division of Nephrology, Indiana University School of Medicine and Deaconess Health System, Evansville, Indiana, USA
11 Department of
AuthorAffiliation_xml – name: 6 Department of Medicine, Renal Transplant Program, University of Missouri-Kansas City School of Medicine, Saint Luke's Health System, Kansas City, Missouri, USA
– name: Department of Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Rochester, USA
– name: 1 Department of Medicine, Division of Nephrology, Henry Ford Hospital, Detroit, Michigan, USA
– name: 3 Department of Medicine, Division of Nephrology, Indiana University School of Medicine and Deaconess Health System, Evansville, Indiana, USA
– name: 8 Department of Medicine, Division of Nephrology, University of Mississippi Medical Center, Jackson, Mississippi, USA
– name: 4 Department of Internal Medicine, East Tennessee State University, Johnson City, Tennessee, USA
– name: 7 Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA
– name: 9 Department of Military and Community Medicine, Phramongkutklao College of Medicine, Mahidol University, Bangkok, Thailand
– name: 5 Department of Internal Medicine, Bassett Medical Center, Cooperstown, New York, USA
– name: 11 Department of Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Jacksonville, Florida, USA
– name: 2 Department of Internal Medicine, University of Arizona, Tucson, Arizona, USA
– name: 10 Department of Medicine, Division of Infectious Diseases, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
Author_xml – sequence: 1
  givenname: Charat
  surname: Thongprayoon
  fullname: Thongprayoon, Charat
  organization: Department of Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Rochester
– sequence: 2
  givenname: Nadeen
  surname: Khoury
  fullname: Khoury, Nadeen
  organization: Department of Medicine, Division of Nephrology, Henry Ford Hospital, Detroit, Michigan
– sequence: 3
  givenname: Tarun
  surname: Bathini
  fullname: Bathini, Tarun
  organization: Department of Internal Medicine, University of Arizona, Tucson, Arizona
– sequence: 4
  givenname: Narothama
  surname: Aeddula
  fullname: Aeddula, Narothama
  organization: Department of Medicine, Division of Nephrology, Indiana University School of Medicine and Deaconess Health System, Evansville, Indiana
– sequence: 5
  givenname: Boonphiphop
  surname: Boonpheng
  fullname: Boonpheng, Boonphiphop
  organization: Department of Internal Medicine, East Tennessee State University, Johnson City, Tennessee
– sequence: 6
  givenname: Ploypin
  surname: Lertjitbanjong
  fullname: Lertjitbanjong, Ploypin
  organization: Department of Internal Medicine, Bassett Medical Center, Cooperstown, New York
– sequence: 7
  givenname: Kanramon
  surname: Watthanasuntorn
  fullname: Watthanasuntorn, Kanramon
  organization: Department of Internal Medicine, Bassett Medical Center, Cooperstown, New York
– sequence: 8
  givenname: Napat
  surname: Leeaphorn
  fullname: Leeaphorn, Napat
  organization: Department of Medicine, Renal Transplant Program, University of Missouri-Kansas City School of Medicine, Saint Luke′s Health System, Kansas City, Missouri
– sequence: 9
  givenname: Supavit
  surname: Chesdachai
  fullname: Chesdachai, Supavit
  organization: Department of Medicine, University of Minnesota, Minneapolis, Minnesota
– sequence: 10
  givenname: Aldo
  surname: Torres-Ortiz
  fullname: Torres-Ortiz, Aldo
  organization: Department of Medicine, Division of Nephrology, University of Mississippi Medical Center, Jackson, Mississippi
– sequence: 11
  givenname: Wisit
  surname: Kaewput
  fullname: Kaewput, Wisit
  organization: Department of Military and Community Medicine, Phramongkutklao College of Medicine, Mahidol University, Bangkok
– sequence: 12
  givenname: Jackrapong
  surname: Bruminhent
  fullname: Bruminhent, Jackrapong
  organization: Department of Medicine, Division of Infectious Diseases, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok
– sequence: 13
  givenname: Michael
  surname: Mao
  fullname: Mao, Michael
  organization: Department of Medicine, Division of Nephrology and Hypertension, Mayo Clinic, Jacksonville, Florida
– sequence: 14
  givenname: Wisit
  surname: Cheungpasitporn
  fullname: Cheungpasitporn, Wisit
  organization: Department of Medicine, Division of Nephrology, University of Mississippi Medical Center, Jackson, Mississippi
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33100749$$D View this record in MEDLINE/PubMed
BookMark eNp9ktuLEzEYxQdZcS_65LsMCCJIa-4zERTqsurCgi_2UUImlzbdmWRMZlr635va7bqVRUJISH7fSb7DOS9OfPCmKF5CMCUQ4Pfz2XQ-EzUXkD8pzgCvyKSqMTk57CvOTovzlFYAMMYAeVacYgwBqAg_K35e9U6bzoU2LLZlsGUv4zqsXRxT-RnyUnqdZwZkKbvgF-Wt095syyFKn_pW-qGMRrneGT-kD-Ws7MwgJ9LLdptcel48tbJN5sXdelHMv1z9uPw2ufn-9fpydjNRjNIw0YQpBAzUGqFKAyMriAAzvKJQWaxqUlnLFG5swxDUDYSWQ1UDoDCXlawpviiu97o6yJXoo-tk3IognfhzEOJCyDg41RphsVbQIEYtBUTTinOKGwVribjGRjZZ69Neqx-bzmiVG4uyPRI9vvFuKRZhLSpKGKhAFnh7JxDDr9GkQXQuKdNms0wYk0CEEgI44jv09T_oKowxm5cpihEnsAbwvxRBNPeBAPpLLWRu03kb8u_U7mkxYxgAhGqEMzV9hMpjFwKVg2VdPj8qePOgYGlkOyxTaMfBBZ-OwXd7UMWQUjT23jIIxC6oIqf0ENRMv3ro8j17SGYGPu6BTWgHE9NtO25MFJm99WHzmGY2A4pDnPFvufn3cA
CitedBy_id crossref_primary_10_3390_ijms24119147
crossref_primary_10_3389_fmed_2023_1170100
crossref_primary_10_1007_s00277_022_04831_w
crossref_primary_10_1016_j_meegid_2022_105307
crossref_primary_10_1093_ofid_ofad079
crossref_primary_10_1016_j_clim_2023_109782
crossref_primary_10_1007_s00467_024_06378_6
crossref_primary_10_2147_IDR_S321936
crossref_primary_10_3389_fmed_2023_1195419
ContentType Journal Article
Copyright Copyright: © 2020 Urology Annals.
COPYRIGHT 2020 Medknow Publications and Media Pvt. Ltd.
2020. This article is published under (http://creativecommons.org/licenses/by-nc-sa/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright: © 2020 Urology Annals 2020
Copyright_xml – notice: Copyright: © 2020 Urology Annals.
– notice: COPYRIGHT 2020 Medknow Publications and Media Pvt. Ltd.
– notice: 2020. This article is published under (http://creativecommons.org/licenses/by-nc-sa/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Copyright: © 2020 Urology Annals 2020
DBID NPM
AAYXX
CITATION
K9.
3V.
7X7
7XB
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
M0S
M2O
MBDVC
PADUT
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOA
DOI 10.4103/UA.UA_89_19
DatabaseName PubMed
CrossRef
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Corporate)
ProQuest Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni Edition)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
Research Library Prep
Health & Medical Collection (Alumni Edition)
ProQuest Research Library
Research Library (Corporate)
Research Library China
Publicly Available Content Database (Proquest) (PQ_SDU_P3)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle PubMed
CrossRef
ProQuest Health & Medical Complete (Alumni)
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
ProQuest Central Basic
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Research Library (Alumni Edition)
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Research Library
Research Library China
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

Publicly Available Content Database

ProQuest Health & Medical Complete (Alumni)
PubMed
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: http://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 0974-7834
EndPage 247
ExternalDocumentID oai_doaj_org_article_f3dc1e265f504d579953bc18a29d3eab
A630022823
10_4103_UA_UA_89_19
33100749
10.4103/UA.UA_89_19_241_Epidemio
Genre Journal Article
GroupedDBID -
29Q
2WC
3V.
53G
5VS
7X7
8FI
8G5
ABDBF
ABPTK
ABUWG
ACGFS
ADACO
ADBBV
AFKRA
AHMBA
ALMA_UNASSIGNED_HOLDINGS
AZQEC
BAWUL
BBAFP
BCNDV
BENPR
BPHCQ
BVXVI
DIK
DWQXO
E3Z
EBD
EBS
EJD
ESX
F5P
FYUFA
GROUPED_DOAJ
GUQSH
GX1
HYE
IAO
IEA
IHR
IHW
INH
INR
ITC
KQ8
M2O
MBDVC
M~E
O5R
O5S
OBODZ
OK1
P2P
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
PROAC
RIG
RMW
RNS
RPM
TUS
W3E
---
8FJ
ABXLX
ADRAZ
ALIPV
AOIJS
CCPQU
EOJEC
GNUQQ
H13
HMCUK
IL9
IPNFZ
M48
NPM
OVD
PADUT
PGMZT
TEORI
TR2
UKHRP
~8M
AAYXX
CITATION
K9.
7XB
8FK
Q9U
7X8
5PM
ID FETCH-LOGICAL-c655o-d46c20e1dd227d0ea71206e9751cf3c847ff6c3bfb621db11f91c800c39a7a853
IEDL.DBID RPM
ISSN 0974-7796
IngestDate Tue Oct 22 15:05:23 EDT 2024
Tue Sep 17 20:52:28 EDT 2024
Fri Aug 16 23:33:34 EDT 2024
Tue Nov 19 05:52:49 EST 2024
Thu Oct 10 21:18:06 EDT 2024
Tue Nov 19 21:09:46 EST 2024
Tue Nov 12 23:05:22 EST 2024
Tue Aug 20 22:10:48 EDT 2024
Fri Aug 23 00:32:34 EDT 2024
Sat Sep 28 08:20:24 EDT 2024
Tue Jan 05 18:26:27 EST 2021
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords meta-analysis
systematic reviews
renal transplantation
parvovirus B19
Kidney transplantation
Language English
License http://creativecommons.org/licenses/by-nc-sa/4.0
Copyright: © 2020 Urology Annals.
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c655o-d46c20e1dd227d0ea71206e9751cf3c847ff6c3bfb621db11f91c800c39a7a853
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546070/
PMID 33100749
PQID 2532941801
PQPubID 226454
PageCount 7
ParticipantIDs doaj_primary_oai_doaj_org_article_f3dc1e265f504d579953bc18a29d3eab
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7546070
proquest_miscellaneous_2454409290
proquest_journals_2532941801
proquest_journals_2425504202
gale_infotracmisc_A630022823
gale_infotracacademiconefile_A630022823
gale_healthsolutions_A630022823
crossref_primary_10_4103_UA_UA_89_19
pubmed_primary_33100749
wolterskluwer_medknow_10_4103_UA_UA_89_19_241_Epidemio
ProviderPackageCode W3E
RMW
PublicationCentury 2000
PublicationDate 20200701
PublicationDateYYYYMMDD 2020-07-01
PublicationDate_xml – month: 7
  year: 2020
  text: 20200701
  day: 01
PublicationDecade 2020
PublicationPlace India
PublicationPlace_xml – name: India
– name: Mumbai
PublicationTitle Urology annals
PublicationTitleAlternate Urol Ann
PublicationYear 2020
Publisher Wolters Kluwer India Pvt. Ltd
Medknow Publications and Media Pvt. Ltd
Medknow Publications & Media Pvt. Ltd
Wolters Kluwer - Medknow
Wolters Kluwer Medknow Publications
Publisher_xml – name: Wolters Kluwer India Pvt. Ltd
– name: Medknow Publications and Media Pvt. Ltd
– name: Medknow Publications & Media Pvt. Ltd
– name: Wolters Kluwer - Medknow
– name: Wolters Kluwer Medknow Publications
References Carraturo (key-10.4103/0974-7796.286327-21) 2012
Egbuna (key-10.4103/0974-7796.286327-17) 2006
DerSimonian (key-10.4103/0974-7796.286327-31) 1986
Khameneh (key-10.4103/0974-7796.286327-23) 2014
Parsyan (key-10.4103/0974-7796.286327-39) 2007
Anderson (key-10.4103/0974-7796.286327-3) 1986
Cavallo (key-10.4103/0974-7796.286327-14) 2003
Porignaux (key-10.4103/0974-7796.286327-22) 2013
Bertoni (key-10.4103/0974-7796.286327-10) 1997
Čapenko (key-10.4103/0974-7796.286327-20) 2012
Zolnourian (key-10.4103/0974-7796.286327-12) 2000
Ardalan (key-10.4103/0974-7796.286327-18) 2008
Higgins (key-10.4103/0974-7796.286327-32) 2003
Vanrenterghem (key-10.4103/0974-7796.286327-35) 2004
Jordan (key-10.4103/0974-7796.286327-7) 1998
Ardalan (key-10.4103/0974-7796.286327-36) 2008
Waldman (key-10.4103/0974-7796.286327-8) 2007
Easterbrook (key-10.4103/0974-7796.286327-33) 1991
Fishman (key-10.4103/0974-7796.286327-37) 2017
Pambrun (key-10.4103/0974-7796.286327-24) 2014
Cossart (key-10.4103/0974-7796.286327-1) 1975
Razonable (key-10.4103/0974-7796.286327-4) 2016
Barsoum (key-10.4103/0974-7796.286327-29) 2002
Baek (key-10.4103/0974-7796.286327-26) 2017
Moher (key-10.4103/0974-7796.286327-30) 2009
Pattison (key-10.4103/0974-7796.286327-6) 1981
Malyszko (key-10.4103/0974-7796.286327-13) 2002
Woolf (key-10.4103/0974-7796.286327-9) 1989
Plentz (key-10.4103/0974-7796.286327-5) 2013
Gallinella (key-10.4103/0974-7796.286327-11) 1999
Eid (key-10.4103/0974-7796.286327-16) 2006
Krishnan (key-10.4103/0974-7796.286327-25) 2015
Bertoni (key-10.4103/0974-7796.286327-34) 1997
Jordan (key-10.4103/0974-7796.286327-28) 2011
Eid (key-10.4103/0974-7796.286327-2) 2013
Cheungpasitporn (key-10.4103/0974-7796.286327-38) 2018
Xiao (key-10.4103/0974-7796.286327-27) 2013
Ki (key-10.4103/0974-7796.286327-15) 2005
Park (key-10.4103/0974-7796.286327-19) 2009
References_xml – start-page: 856
  volume-title: Infection in organ transplantation
  year: 2017
  ident: key-10.4103/0974-7796.286327-37
  publication-title: Am J Transplant
  contributor:
    fullname: Fishman
– start-page: 1153
  volume-title: Clinical manifestations of human parvovirus B19 in adults
  year: 1989
  ident: key-10.4103/0974-7796.286327-9
  publication-title: Arch Intern Med
  contributor:
    fullname: Woolf
– start-page: 428
  volume-title: Not the usual viral suspects: Parvovirus B19, West Nile virus, and human T-cell lymphotrophic virus infections after kidney transplantation
  year: 2016
  ident: key-10.4103/0974-7796.286327-4
  publication-title: Semin Nephrol
  contributor:
    fullname: Razonable
– start-page: 97
  volume-title: Human parvovirus B19: Prevalence of viral DNA in volunteer blood donors and clinical outcomes of transfusion recipients
  year: 1998
  ident: key-10.4103/0974-7796.286327-7
  publication-title: Vox Sang
  contributor:
    fullname: Jordan
– start-page: 225
  volume-title: A cluster of parvovirus B19 infections in renal transplant recipients: A prospective case series and review of the literature
  year: 2006
  ident: key-10.4103/0974-7796.286327-17
  publication-title: Am J Transplant
  contributor:
    fullname: Egbuna
– start-page: V54
  volume-title: Anaemia after renal transplantation
  year: 2004
  ident: key-10.4103/0974-7796.286327-35
  publication-title: Nephrol Dial Transplant
  contributor:
    fullname: Vanrenterghem
– start-page: e13194
  volume-title: De novo donor-specific antibody following BK nephropathy: The incidence and association with antibody-mediated rejection
  year: 2018
  ident: key-10.4103/0974-7796.286327-38
  publication-title: Clin Transplant
  contributor:
    fullname: Cheungpasitporn
– start-page: e12754
  volume-title: Risk factors and long-term outcomes of parvovirus B19 infection in kidney transplant patients
  year: 2017
  ident: key-10.4103/0974-7796.286327-26
  publication-title: Transpl Infect Dis
  contributor:
    fullname: Baek
– start-page: 557
  volume-title: Measuring in consistency in meta-analyses
  year: 2003
  ident: key-10.4103/0974-7796.286327-32
  publication-title: BMJ
  contributor:
    fullname: Higgins
– start-page: 811
  volume-title: Occurrence and clinical role of active parvovirus B19 infection in transplant recipients
  year: 1999
  ident: key-10.4103/0974-7796.286327-11
  publication-title: Eur J Clin Microbiol Infect Dis
  contributor:
    fullname: Gallinella
– start-page: 522
  volume-title: Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay
  year: 1986
  ident: key-10.4103/0974-7796.286327-3
  publication-title: J Clin Microbiol
  contributor:
    fullname: Anderson
– start-page: 152
  volume-title: Aplastic anemia due to B19 parvovirus infection in cadaveric renal transplant recipients: An underestimated infectious disease in the immunocompromised host
  year: 1997
  ident: key-10.4103/0974-7796.286327-10
  publication-title: J Nephrol
  contributor:
    fullname: Bertoni
– start-page: 751
  volume-title: Incidence and clinical significance of human parvovirus B19 infection in kidney transplant recipients
  year: 2005
  ident: key-10.4103/0974-7796.286327-15
  publication-title: Clin Transplant
  contributor:
    fullname: Ki
– start-page: 16
  issn: 1319-2442
  volume-title: The seroprevalence of parvovirus B19 among kidney transplant recipients: A single-center study
  year: 2014
  ident: key-10.4103/0974-7796.286327-23
  publication-title: Saudi J Kidney Dis Transpl
  contributor:
    fullname: Khameneh
– start-page: 196
  volume-title: Clinical aspects of intravenous immunoglobulin use in solid organ transplant recipients
  year: 2011
  ident: key-10.4103/0974-7796.286327-28
  publication-title: Am J Transplant
  contributor:
    fullname: Jordan
– start-page: 425
  volume-title: Treatment of parvovirus B-19 (PV B-19) infection allows for successful kidney transplantation without disease recurrence
  year: 2002
  ident: key-10.4103/0974-7796.286327-29
  publication-title: Am J Transplant
  contributor:
    fullname: Barsoum
– start-page: 1340
  volume-title: Postrenal transplant hemophagocytic lymphohistiocytosis and thrombotic microangiopathy associated with parvovirus b19 infection
  year: 2008
  ident: key-10.4103/0974-7796.286327-36
  publication-title: Am J Transplant
  contributor:
    fullname: Ardalan
– start-page: 455
  volume-title: Clinical implications of quantitative real time-polymerase chain reaction of parvovirus B19 in kidney transplant recipients – A prospective study
  year: 2009
  ident: key-10.4103/0974-7796.286327-19
  publication-title: Transpl Int
  contributor:
    fullname: Park
– start-page: 137
  volume-title: Parvovirus B19 microepidemic in renal transplant recipients with thrombotic microangiopathy and allograft vasculitis
  year: 2008
  ident: key-10.4103/0974-7796.286327-18
  publication-title: Exp Clin Transplant
  contributor:
    fullname: Ardalan
– start-page: 664
  volume-title: Parvovirus infections and hypoplastic crisis in sickle-cell anaemia
  year: 1981
  ident: key-10.4103/0974-7796.286327-6
  publication-title: Lancet
  contributor:
    fullname: Pattison
– start-page: 3211
  volume-title: Parvovirus B19 infection and IGF system components in relation to erythropoiesis in dialyzed patients and kidney transplant recipients
  year: 2002
  ident: key-10.4103/0974-7796.286327-13
  publication-title: Transplant Proc
  contributor:
    fullname: Malyszko
– start-page: 87
  volume-title: Effects of parvovirus B19 infection in renal transplant recipients: A retrospective review of three cases
  year: 2015
  ident: key-10.4103/0974-7796.286327-25
  publication-title: Int J Angiol
  contributor:
    fullname: Krishnan
– start-page: 361
  volume-title: B19 virus infection in renal transplant recipients
  year: 2003
  ident: key-10.4103/0974-7796.286327-14
  publication-title: J Clin Virol
  contributor:
    fullname: Cavallo
– start-page: 1115
  volume-title: Frequent occurrence of parvovirus B19 DNAemia in the first year after kidney transplantation
  year: 2013
  ident: key-10.4103/0974-7796.286327-22
  publication-title: J Med Virol
  contributor:
    fullname: Porignaux
– start-page: 72
  volume-title: Parvovirus-like particles in human sera
  year: 1975
  ident: key-10.4103/0974-7796.286327-1
  publication-title: Lancet
  contributor:
    fullname: Cossart
– start-page: 428
  volume-title: Identification and genetic diversity of two human parvovirus B19 genotype 3 subtypes
  year: 2007
  ident: key-10.4103/0974-7796.286327-39
  publication-title: J Gen Virol
  contributor:
    fullname: Parsyan
– start-page: 867
  volume-title: Publication bias in clinical research
  year: 1991
  ident: key-10.4103/0974-7796.286327-33
  publication-title: Lancet
  contributor:
    fullname: Easterbrook
– start-page: 201
  volume-title: AST Infectious Diseases Community of Practice.Human parvovirus B19 in solid organ transplantation
  year: 2013
  ident: key-10.4103/0974-7796.286327-2
  publication-title: Am J Transplant
  contributor:
    fullname: Eid
– start-page: e1000097
  volume-title: Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
  year: 2009
  ident: key-10.4103/0974-7796.286327-30
  publication-title: PLoS Med
  contributor:
    fullname: Moher
– start-page: 177
  volume-title: Meta-analysis in clinical trials
  year: 1986
  ident: key-10.4103/0974-7796.286327-31
  publication-title: Control Clinic Trials
  contributor:
    fullname: DerSimonian
– start-page: 1593
  volume-title: Clinical investigation of human parvovirus B19 infection after renal transplantation in China
  year: 2013
  ident: key-10.4103/0974-7796.286327-27
  publication-title: Transplant Proc
  contributor:
    fullname: Xiao
– start-page: 40
  volume-title: Parvovirus B19 infection after transplantation: A review of 98 cases
  year: 2006
  ident: key-10.4103/0974-7796.286327-16
  publication-title: Clin Infect Dis
  contributor:
    fullname: Eid
– start-page: S47
  volume-title: Parvovirus B19 and the kidney
  year: 2007
  ident: key-10.4103/0974-7796.286327-8
  publication-title: Clin J Am Soc Nephrol
  contributor:
    fullname: Waldman
– start-page: 252914
  volume-title: An association between BK virus replication in bone marrow and cytopenia in kidney-transplant recipients
  year: 2014
  ident: key-10.4103/0974-7796.286327-24
  publication-title: J Transplant
  contributor:
    fullname: Pambrun
– start-page: 818
  volume-title: Unusual incidence of aplastic anaemia due to B-19 parvovirus infection in renal transplant recipients
  year: 1997
  ident: key-10.4103/0974-7796.286327-34
  publication-title: Transplant Proc
  contributor:
    fullname: Bertoni
– start-page: 299
  volume-title: Anemia as a complication of parvovirus b19 infection in renal transplant recipients
  year: 2012
  ident: key-10.4103/0974-7796.286327-20
  publication-title: Medicina (Kaunas)
  contributor:
    fullname: Čapenko
– start-page: 102829
  volume-title: Parvovirus B19 infection and severe anemia in renal transplant recipients
  year: 2012
  ident: key-10.4103/0974-7796.286327-21
  publication-title: ScientificWorldJournal
  contributor:
    fullname: Carraturo
– start-page: 443
  volume-title: Low-level DNAemia of parvovirus B19 (genotypes 1-3) in adult transplant recipients is not associated with anaemia
  year: 2013
  ident: key-10.4103/0974-7796.286327-5
  publication-title: J Clin Virol
  contributor:
    fullname: Plentz
– start-page: 2198
  volume-title: Parvovirus B19 in kidney transplant patients
  year: 2000
  ident: key-10.4103/0974-7796.286327-12
  publication-title: Transplantation
  contributor:
    fullname: Zolnourian
SSID ssj0066604
Score 2.2735946
Snippet Background: Persistent anemia has been described in kidney transplant (KTx) recipients with parvovirus B19 virus infection. However, the epidemiology of...
Persistent anemia has been described in kidney transplant (KTx) recipients with parvovirus B19 virus infection. However, the epidemiology of parvovirus B19 and...
BACKGROUNDPersistent anemia has been described in kidney transplant (KTx) recipients with parvovirus B19 virus infection. However, the epidemiology of...
SourceID doaj
pubmedcentral
proquest
gale
crossref
pubmed
wolterskluwer
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 241
SubjectTerms Analysis
Anemia
Bias
Blood
Bone marrow
Cytomegalovirus
Cytotoxicity
Deoxyribonucleic acid
DNA
Epidemiology
Health aspects
Immunoglobulins
Infection
Infections
Kidney transplantation
Kidney transplants
Medical research
Meta-analysis
Original
parvovirus b19
Patients
renal transplantation
Studies
Systematic review
systematic reviews
Viral infections
Viruses
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEF5BDwgJId4YCixSJU6m3qez3FJI1QtcIBIXtNqniErtKE6K-u-ZXTshhkpcOPjiHVn2PHZmvDPfIHTELYvEMl5yqwwkKCSWVjhRMsujjeDyWAb1Oftcf_o6-TBLMDm7UV-pJqyHB-4ZdxyZdyRQKaKouBcJv4xZRyaGKs-CsXn3reQ2mer3YIjJ8-DASqVqw1rJvjOPk4odz6dv51M9UTqB6-z5ogzZ__fGvOeZ_qyavPOzTSfa3XkuaN9zS6f30N0hnsTT_jvuoxuheYBufRxOzB-ib7PfI2CvcBvx0qwu28vFatPhE6KwaTxcQGBwnjuEzxe-CVd4nUHPfwDfccK_WKa2ye4dnuKLsDalGaBMHqH56ezL-7NyGKlQOilEW3ouHa0C8Z7S2lfB1IRWMqhaEBeZA1cVo3TMRisp8ZaQqIiDmNIxZWoDrv0xOmjaJjxFGGQQUnuJNyZwyysbg-TSVz7WEEfVtkBHW-bqZY-coSHjSDLQIICtDAp0khi_I0lw1_kGKIEelED_SwkK9CqJTfe9ozuj1dMEKEYhq2QFepMpktkCB50Zug_gWxIA1ojycEQJ5ubGy1vV0IO5dzrlbfBmtKLXLwtGFScQDBTo9W45PThVuDWh3aRHCA65NlVVgZ70irbjCUunMDUHXtUjFRwxbbzSLL5nrPBacAm7eoHkSFn1Rd9seZ1E4FWI3irns_8hnufoNk2_KXKV8yE6WK824QW62fnNy2y2vwBI10ak
  priority: 102
  providerName: Directory of Open Access Journals
Title Epidemiology of parvovirus B19 and anemia among kidney transplant recipients: A meta-analysis
URI http://www.urologyannals.com/article.asp?issn=0974-7796;year=2020;volume=12;issue=3;spage=241;epage=247;aulast=Thongprayoon;type=0
https://www.ncbi.nlm.nih.gov/pubmed/33100749
https://www.proquest.com/docview/2425504202
https://www.proquest.com/docview/2532941801
https://search.proquest.com/docview/2454409290
https://pubmed.ncbi.nlm.nih.gov/PMC7546070
https://doaj.org/article/f3dc1e265f504d579953bc18a29d3eab
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6RHhASQrwxlLJIlTg58b7smFtaUvVShASRuKDVPkvUxo7yKOq_Z3Zthxh64uCLd2Sv5-GZ2Z35FqFjrpknmvGU61JBgkJ8qoURKdPcaw8uj0VQn_Ovxefv40_TAJMjul6YWLRv9HxYXS-G1fxnrK1cLsyoqxMbfbk4LQTPQVVHAzSA2LBL0ZvfL4Tj8czArAyFhkWZN015nGRsNJsMZxM5LiUJYKEsrG0XAURzzyNF4P5_f897_unv2smHv-qwr72-imXte87p7DF61EaVeNLM_gm656qn6P5Fu2_-DP2Y_jkI9hbXHi_V6qa-ma-2a3xCSqwqCxcQKBxPH8JXc1u5W7yJ0OfXwH0cUDCWoXly_RFP8MJtVKpaQJPnaHY2_XZ6nrYHK6QmF6JOLc8NzRyxltLCZk4VhGa5KwtBjGcGHJb3uWHa65wSqwnxJTEQWRpWqkKBg3-BDqq6cq8QNmTsQpOJVcpxzTPtXc5zm1lfQDRV6AQdd8yVywY_Q0LeEcQhQRadOBJ0Ehi_Iwmg1_FGvbqUreilZ9YQR3PhRcatCFB2TMMEFC0tcwre9S6ITTYdpDvTlZMAK0Yht2QJ-hApgvECB41qexDgWwIMVo_ysEcJRmf6w51qyNbo1zJkbzAzmtG7hwWjJScQEiTo_W44PDjUuVWu3oZHCA4ZNy2zBL1sFG3Hk05fE1T0VLDHtP4IGFBEDG8NJkF5T1nlomm5vEsiMBUiO-V8_d-vfIMe0LBCEQucD9HBZrV1b9FgbbdHcfnjKBrvb6IGR4w
link.rule.ids 230,315,729,782,786,866,887,2106,27933,27934,53800,53802
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF7RIgES4lnAUKiRKnFysi_bMbe0pAqirZBoJC5otU-I2thRHkX998yu7VBDTz344hnZ652ZnZn1zLcI7XPFHFGMJ1wVEhIU4hKV6jRhijvlwOWxAOoz_paffh98GnmYnLTthQlF-1pNe-XFrFdOf4XayvlM99s6sf7Xk8M85Rmoan8L3QV7xbhN0usFGALycGogLnypYV5kdVseJ5j1J8PeZCgGhSAeLpT53e3cw2he80kBuv__Bfqah_q3evLh78r_2V6eh8L2a-7p6PEtP-wJetTEo_GwJj9Fd2z5DN07af64P0c_Rn-PkL2KKxfP5eKyupwu1sv4gBSxLA1cwCDjcG5RfD41pb2KVwE0_QLkFnv8jLlvu1x-jIfxzK5kIhsolB00ORqdHY6T5kiGRGdpWiWGZ5piS4yhNDfYypxQnNkiT4l2TIOrcy7TTDmVUWIUIa4gGiSkWSFzCaHBC7RdVqV9hWJNBta3pxgpLVccK2cznhlsXA5xWK4itN8KRcxr5A0BGYsXowAZtmKM0IEX2IbFw2WHG9Xip2jmVjhmNLE0S12KuUk9CB5TMABJC8OshHfteXGLuvd0Y_Ri6AHJKGSlLEIfAoc3e5hBLZvuBfgWD6DV4dztcIK56i65VSnRLBdL4fM-GBnF9GZyymjBCQQTEXq_IfsH-wq50lZr_4iUQ65OCxyhl7WCbuak1fMI5R3V7UxalwIaGrDGG42MUNZRcjGrmzVvkggMhYhWOV_f-pV76P747ORYHH8-_fIGPaB-nyOUSe-i7dVibd-iraVZvwum_wdCaFwc
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZokSokxLsQKNRIlTilGz-SbLht210VQatKsBIXZPkJq3aT1T6K-u8ZO8mygZ7gkEs8ShzPjGfGmfkGoQOumCOK8ZirQkKAQlysUp3GTHGnHJg8FkB9Tj_n51_7J0MPk7Nu9RWS9rWaHJZX08Ny8iPkVs6mutfmifUuzo7zlGcgqr2Zcb0tdBd0NqFtoF5vwuCUh86BSeHTDfMiq0vzOElYbzw4HA9EvxDEQ4Yyf8KdeyjNDbsU4Pv_3qQ3rNSfGZT3f1b-7_biMiS3b5io0cP_-LhH6EHjl-JBTfIY3bHlE7Rz1vx5f4q-DX-3kr3BlcMzOb-urifz1QIfkQLL0sAFBBKH_kX4cmJKe4OXATz9CviHPY7GzJdfLt7jAZ7apYxlA4nyDI1Hwy_Hp3HTmiHWWZpWseGZpoklxlCam8TKnNAks0WeEu2YBpPnXKaZciqjxChCXEE0-KaaFTKX4CLsou2yKu0LhDXpW1-mYqS0XPFEOZvxzCTG5eCP5SpCBy1jxKxG4BAQuXhWCuBjy8oIHXmmrUk8bHa4Uc2_i2Z9hWNGE0uz1KUJN6kHw2MKJiBpYZiV8K59z3JR16CulV8MPDAZheiURehdoPDqDyuoZVPFAN_igbQ6lHsdSlBb3R1uxUo028ZC-PgPZkYTevtwymjBCTgVEXq7HvYP9plypa1W_hEph5idFkmEntdCul6TVtYjlHfEt7No3RGQ0oA53khlhLKOoItpXbR5G0dgKkS0wvnyn1-5j3YuTkbi04fzj6_QPeqPO0K29B7aXs5X9jXaWpjVm6D9vwAXFF6c
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Epidemiology+of+parvovirus+B19+and+anemia+among+kidney+transplant+recipients%3A+A+meta-analysis&rft.jtitle=Urology+annals&rft.au=Thongprayoon%2C+Charat&rft.au=Khoury%2C+Nadeen+J&rft.au=Bathini%2C+Tarun&rft.au=Aeddula%2C+Narothama+Reddy&rft.date=2020-07-01&rft.issn=0974-7796&rft.volume=12&rft.issue=3&rft.spage=241&rft.epage=247&rft_id=info:doi/10.4103%2FUA.UA_89_19&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0974-7796&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0974-7796&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0974-7796&client=summon